RBC Capital top analyst Mark Mahaney is out with an upbeat research report on Facebook Inc (NASDAQ:FB) on the heels of what he deems “wicked strong” fourth-quarter results. In …
FBR analyst Vernon Bernardino met with Novavax, Inc. (NASDAQ:NVAX) management last week to discuss fundamentals and future 2017 clinical development.
William Blair analyst Tim Lugo is downgrading CoLucid (NASDAQ:CLCD) following the announcement of the firm’s pending acquisition by Eli Lilly and Co (NYSE:LLY), …
William Blair analyst Ralph Schackart offers a bullish take on Netflix, Inc. (NASDAQ:NFLX) after adding the online streaming giant’s addition to the 246th Current …
Top analyst Irina Rivkind Koffler at Mizuho is taking a sharp left from the sidelines on Eagle Pharmaceuticals Inc (NASDAQ:EGRX) on the heels …
The biotech-verse was buzzing this week after Kite Pharma Inc (NASDAQ:KITE) submitted an IND application for its pipeline cancer drug that sent shares rising. …
Mizuho analyst Irina Rivkind Koffler chimes in on Allergan plc Ordinary Shares (NYSE:AGN) on back of key competitor Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) announcing positive top-line Phase III …
BTIG analyst Mark Palmer is stepping left and downgrading Bancorp Inc (NASDAQ:TBBK) from a Buy to a Neutral rating after the financial holding firm’s shares achieved …
J.P.
Baird top analyst Colin Sebastian puts in his two cents on Amazon.com, Inc.
